UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007990
Receipt No. R000009395
Scientific Title A phase II study of first line chemotherapy by eribulin mesilate for HER2 negative recurrent breast cancer
Date of disclosure of the study information 2012/05/19
Last modified on 2018/05/26 15:20:39

No. Disposal Last modified on Item of update
1 Insert 2012/05/19 15:39:34
2 Update 2012/05/19 15:47:11 Date of disclosure of the study information
3 Update 2012/05/19 16:14:14 Institutions
4 Update 2012/12/22 16:29:08 Email1
Institutions
5 Update 2012/12/22 16:34:49 Institutions
6 Update 2014/05/19 12:17:09 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
7 Update 2014/05/19 12:19:44 Email
8 Update 2016/09/10 12:22:28 Name of primary sponsor
Organization
9 Update 2016/09/10 12:26:02 Institutions
10 Update 2016/11/26 15:25:38 Recruitment status
11 Update 2018/05/26 15:20:39 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results


Contact us.